Provider costs of treating opioid dependence with extended‐release buprenorphine in Australia

Ähnliche Einträge

• Health utility among people who regularly use opioids in Australia
  von: Anh Dam Tran, et al.
  Veröffentlicht: (2024)
• A discrete choice experiment: Understanding patient preferences for managing chronic non‐cancer pain
  von: Gabrielle Campbell, et al.
  Veröffentlicht: (2024)
• benmcdonough20/slow_dynamics_numerics: Initial release
  von: Benjamin McDonough
  Veröffentlicht: (2025)
• Commentary on Yang et al.: The need for a renewed focus on identifying and responding to chronic pain among people with substance use disorders
  von: Gabrielle Campbell, et al.
  Veröffentlicht: (2024)
• Treatment satisfaction and patient reported outcomes among people with opioid use disorder participating in an open‐label, non‐randomised trial of long‐acting injectable buprenorphine treatment in Australian custodial settings
  von: Bethany White, et al.
  Veröffentlicht: (2025)